APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A

Compare research editions
View pricing & licenses

Selected research

Industry Research

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Research Report 2026

19 December 2025119 pages

Choose your research edition.

Industry ResearchDual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A include Carna Biosciences Inc, Felicitex Therapeutics, ManRos Therapeutics, NeuroNascent Inc and Pharmasum Therapeutics AS, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market by Company

Carna Biosciences Inc

Felicitex Therapeutics

ManRos Therapeutics

NeuroNascent Inc

Pharmasum Therapeutics AS

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Type

PST-900

NNI-351

FX-9847

Others

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Application

Pancreatic Cancer

Down Syndrome

Colon Cancer

Lung Cancer

Others

Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Manufacturers (2021-2026) Table 8. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue of Manufacturers (2021-2026) Table 9. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Product Type & Application Table 14. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Carna Biosciences Inc Company Information Table 19. Carna Biosciences Inc Business Overview Table 20. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 22. Carna Biosciences Inc Recent Developments Table 23. Felicitex Therapeutics Company Information Table 24. Felicitex Therapeutics Business Overview Table 25. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 27. Felicitex Therapeutics Recent Developments Table 28. ManRos Therapeutics Company Information Table 29. ManRos Therapeutics Business Overview Table 30. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 32. ManRos Therapeutics Recent Developments Table 33. NeuroNascent Inc Company Information Table 34. NeuroNascent Inc Business Overview Table 35. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 37. NeuroNascent Inc Recent Developments Table 38. Pharmasum Therapeutics AS Company Information Table 39. Pharmasum Therapeutics AS Business Overview Table 40. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio Table 42. Pharmasum Therapeutics AS Recent Developments Table 43. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 44. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2021-2026) & (K Units) Table 45. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Region (2021-2026) Table 46. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region (2027-2032) & (K Units) Table 47. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Region (2027-2032) Table 48. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2021-2026) & (US$ Million) Table 49. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2021-2026) Table 50. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region (2027-2032) & (US$ Million) Table 51. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Region (2027-2032) Table 52. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 53. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 54. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 55. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2026) & (US$ Million) Table 56. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2027-2032) & (US$ Million) Table 57. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 59. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 60. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2026) & (US$ Million) Table 61. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2027-2032) & (US$ Million) Table 62. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 63. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 64. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 65. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2026) & (US$ Million) Table 66. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2027-2032) & (US$ Million) Table 67. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 68. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 69. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 70. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2026) & (US$ Million) Table 71. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2027-2032) & (US$ Million) Table 72. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 73. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2026) & (K Units) Table 74. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2027-2032) & (K Units) Table 75. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2026) & (US$ Million) Table 76. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2027-2032) & (US$ Million) Table 77. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2026) & (K Units) Table 78. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2027-2032) & (K Units) Table 79. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2026) Table 80. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2027-2032) Table 81. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021-2026) & (US$ Million) Table 82. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2027-2032) & (US$ Million) Table 83. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2026) Table 84. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2027-2032) Table 85. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2021-2026) & (US$/Unit) Table 86. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2027-2032) & (US$/Unit) Table 87. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2026) & (K Units) Table 88. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2027-2032) & (K Units) Table 89. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2026) Table 90. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2027-2032) Table 91. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021-2026) & (US$ Million) Table 92. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2027-2032) & (US$ Million) Table 93. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2026) Table 94. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2027-2032) Table 95. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2021-2026) & (US$/Unit) Table 96. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2027-2032) & (US$/Unit) Table 97. Key Raw Materials Table 98. Raw Materials Key Suppliers Table 99. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors List Table 100. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers List Table 101. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends Table 102. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers Table 103. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints Table 104. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Image Figure 5. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (2021-2032) & (US$ Million) Figure 7. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (2021-2032) & (K Units) Figure 8. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price (US$/Unit) & (2021-2032) Figure 9. PST-900 Product Image Figure 10. NNI-351 Product Image Figure 11. FX-9847 Product Image Figure 12. Others Product Image Figure 13. Pancreatic Cancer Product Image Figure 14. Down Syndrome Product Image Figure 15. Colon Cancer Product Image Figure 16. Lung Cancer Product Image Figure 17. Others Product Image Figure 18. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Share by Manufacturers in 2025 Figure 19. Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters Figure 20. Global Top 5 and 10 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Players Market Share by Revenue in 2025 Figure 21. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 23. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region in 2025 Figure 24. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region in 2025 Figure 25. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2025 Figure 26. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 27. North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2021-2032) Figure 28. United States Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Canada Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2025 Figure 31. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 32. Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2021-2032) Figure 33. Germany Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. France Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. U.K. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Italy Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Netherlands Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2025 Figure 39. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 40. Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2021-2032) Figure 41. China Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Japan Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. South Korea Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. India Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. Australia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. China Taiwan Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Southeast Asia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2025 Figure 50. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 51. South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2021-2032) Figure 52. Mexico Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. Brazil Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Argentina Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country in 2025 Figure 56. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Country (2021-2032) Figure 57. Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Country (2021-2032) Figure 58. Turkey Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. UAE Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2032) Figure 62. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2032) Figure 63. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price (US$/Unit) by Type (2021-2032) Figure 64. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2032) Figure 65. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2032) Figure 66. Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price (US$/Unit) by Application (2021-2032) Figure 67. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain Figure 68. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges

Scope & coverage.

Types
  • PST-900
  • NNI-351
  • FX-9847
  • Others
Applications
  • Pancreatic Cancer
  • Down Syndrome
  • Colon Cancer
  • Lung Cancer
  • Others
Companies covered
  • Carna Biosciences Inc
  • Felicitex Therapeutics
  • ManRos Therapeutics
  • NeuroNascent Inc
  • Pharmasum Therapeutics AS

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size (2021-2032)
  4. 2.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (2021-2032)
  5. 2.2.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Average Price (2021-2032)
  6. 2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 PST-900
  9. 2.3.3 NNI-351
  10. 2.3.4 FX-9847
  11. 2.3.5 Others
  12. 2.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Pancreatic Cancer
  15. 2.4.3 Down Syndrome
  16. 2.4.4 Colon Cancer
  17. 2.4.5 Lung Cancer
  18. 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Product Type & Application
  8. 3.8 Global Manufacturers of Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A, Established Date
  9. 3.9 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Carna Biosciences Inc
  2. 4.1.1 Carna Biosciences Inc Company Information
  3. 4.1.2 Carna Biosciences Inc Business Overview
  4. 4.1.3 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Carna Biosciences Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  6. 4.1.5 Carna Biosciences Inc Recent Developments
  7. 4.2 Felicitex Therapeutics
  8. 4.2.1 Felicitex Therapeutics Company Information
  9. 4.2.2 Felicitex Therapeutics Business Overview
  10. 4.2.3 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Felicitex Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  12. 4.2.5 Felicitex Therapeutics Recent Developments
  13. 4.3 ManRos Therapeutics
  14. 4.3.1 ManRos Therapeutics Company Information
  15. 4.3.2 ManRos Therapeutics Business Overview
  16. 4.3.3 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 ManRos Therapeutics Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  18. 4.3.5 ManRos Therapeutics Recent Developments
  19. 4.4 NeuroNascent Inc
  20. 4.4.1 NeuroNascent Inc Company Information
  21. 4.4.2 NeuroNascent Inc Business Overview
  22. 4.4.3 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 NeuroNascent Inc Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  24. 4.4.5 NeuroNascent Inc Recent Developments
  25. 4.5 Pharmasum Therapeutics AS
  26. 4.5.1 Pharmasum Therapeutics AS Company Information
  27. 4.5.2 Pharmasum Therapeutics AS Business Overview
  28. 4.5.3 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Pharmasum Therapeutics AS Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Product Portfolio
  30. 4.5.5 Pharmasum Therapeutics AS Recent Developments
5 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Scenario by Region
  1. 5.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2021-2032
  3. 5.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2021-2026
  4. 5.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Region: 2027-2032
  5. 5.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2021-2032
  6. 5.3.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2021-2026
  7. 5.3.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Region: 2027-2032
  8. 5.4 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
  9. 5.4.1 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  11. 5.4.3 North America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
  15. 5.5.1 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  17. 5.5.3 Europe Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
  35. 5.7.1 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  37. 5.7.3 South America Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2032)
  2. 6.1.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Type (2021-2032)
  4. 6.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Type (2021-2032)
  5. 6.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2032)
  2. 7.1.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Market Share by Application (2021-2032)
  4. 7.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue by Application (2021-2032)
  5. 7.2.1 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Value Chain Analysis
  2. 8.1.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Production Mode & Process
  5. 8.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Distributors
  8. 8.2.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Customers
9 Global Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Analyzing Market Dynamics
  1. 9.1 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Trends
  2. 9.2 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Drivers
  3. 9.3 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Opportunities and Challenges
  4. 9.4 Dual Specificity Tyrosine Phosphorylation Regulated Kinase 1A Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst